“Stem cell therapy” can refer to very different medical procedures. It may describe an established blood-forming stem-cell transplant for a serious disease, an investigational clinical trial, or a commercially marketed injection with limited clinical evidence.

That distinction should come before any conversation about adding hyperbaric oxygen therapy.

HBOT is being studied alongside several regenerative approaches because oxygen influences circulation, inflammatory signaling, wound repair, and stem or progenitor cell behavior. The research is scientifically interesting, with dramtic changes in stem cell production and patient quality of life changes. 

What Is Hyperbaric Oxygen Therapy?

HBOT involves breathing oxygen inside a chamber at greater-than-normal atmospheric pressure.

Under these conditions, more oxygen dissolves into the bloodstream. This can increase tissue oxygen availability and trigger cellular responses involving blood-vessel growth, inflammation, and repair.

Researchers have also investigated whether pressure-and-oxygen exposure can affect the number or activity of certain circulating stem and progenitor cells.

Does HBOT Increase Stem Cells?

A small human study published in 2006 reported that repeated HBOT exposures were associated with an increase in circulating stem or progenitor cells. After a series of 20 treatments, the researchers reported an approximately 800% increase in the measured cell population. Review the study on PubMed.

That finding is often simplified online into the claim that HBOT “creates stem cells.” The actual meaning is more limited.

The study measured cells circulating in the bloodstream. It did not show that HBOT manufactures a commercial stem-cell product, rebuilds a specific organ, or guarantees that injected or transplanted cells will survive and produce a clinical benefit.

Cell mobilization is a measurable biologic response. It is not proof of a cure.

What Has Combination Research Found?

A randomized controlled study involving 23 people with type 2 diabetes examined a highly specific protocol combining autologous bone-marrow stem-cell transplantation with HBOT. In that study, HBOT was given before and after the stem-cell procedure, and the researchers reported favorable changes in several metabolic measures.

However, this was a small study involving a specialized intrapancreatic procedure. Its results cannot be generalized to orthopedic injections, aesthetic treatments, neurologic conditions, or other regenerative products. Read the diabetes combination study on PubMed.

Preclinical research in diabetic mice has also explored whether HBOT may improve the performance of transplanted mesenchymal stem cells. Animal findings can help explain possible mechanisms, but they do not establish the same benefit in humans. Review the preclinical study on PubMed.

HBOT has also entered formal clinical research around certain blood-forming stem-cell transplants. For example, a National Cancer Institute-listed phase II study evaluated HBOT around cord-blood transplantation and engraftment. A registered clinical trial shows that a question is being studied; it does not by itself prove the treatment works. Review the NCI trial record.

Timing Should Be Coordinated

There is no universal rule that HBOT should always be performed before or after a regenerative procedure.

The appropriate timing may depend on:

• The type and source of cells
• How the cells are processed
• The route of administration
• The tissue or disease being treated
• Whether surgery is involved
• The patient’s medications and medical conditions
• The intended purpose of HBOT
• Whether the procedure is established care or research

A protocol used in one trial should not automatically be transferred to an unrelated treatment.

If the regenerative procedure is being performed as part of a clinical trial, patients should speak with the research team before adding HBOT. An unplanned outside treatment could interfere with study requirements, safety monitoring, or interpretation of the results.

Questions to Ask Before Proceeding

Before paying for any stem-cell procedure, ask the treating clinician:

1. What exact type of cells or biologic product will be used?
2. Is the procedure FDA-approved, performed under an investigational authorization, or offered outside a clinical trial?
3. What human evidence supports its use for my condition?
4. What complications have been reported?
5. Who provides follow-up if a problem occurs?
6. Is HBOT part of the documented protocol?
7. Will the regenerative clinician communicate with the hyperbaric physician?
8. How will success or failure be measured?

Be cautious when a clinic promises guaranteed regeneration, claims one treatment works for many unrelated diseases, or discourages consultation with your regular physician.

HBOT Should Not Be Used to Legitimize an Unproven Procedure

A medically supervised HBOT program cannot turn an inadequately studied product into an established treatment.

The regenerative procedure and the HBOT plan should each be evaluated on their own evidence, safety, and regulatory status. Patients should understand which part is established, which part is off-label, and which part remains experimental.

Medical screening for HBOT is also required. Lung disease, ear and sinus problems, medications, implanted devices, recent illness, and other factors may affect whether treatment is appropriate.

The Bottom Line

Research suggests that HBOT can influence circulating progenitor cells and may interact with biological pathways involved in tissue repair. Early combination studies provide reasons for continued research, but they do not support a blanket claim that HBOT makes every stem-cell therapy safer or more effective.

The most responsible approach is coordination: identify the exact regenerative treatment, review the human evidence, define the role of HBOT, and ensure that every member of the medical team understands the plan.

CTA

Considering a regenerative procedure? Contact RX-O2 to discuss whether a coordinated, medically supervised HBOT plan is appropriate. Please provide information about the exact procedure and treating clinician so the therapies can be evaluated together.

SOURCES

• Stem Cell Mobilization by Hyperbaric Oxygen
• Autologous Bone-Marrow Stem Cells With HBOT for Type 2 Diabetes
• HBOT Combined With Mesenchymal Stem Cells in a Preclinical Diabetes Model
• NCI Phase II Cord-Blood Transplant and HBOT Study

DISCLAIMER

Information on this website is provided for educational purposes only. It is not intended as a substitute for the diagnosis, treatment, and advice of a qualified licensed professional. This website offers general information and in no way should anyone consider that this website represents the practice of medicine. This website assumes no responsibility for how this information is used. Also note that this website frequently updates its contents, due to a variety of reasons.

No statements or implied treatments on this website have been evaluated or approved by the FDA. It is important that you do not reduce, change, or discontinue any medication or treatment without first consulting your doctor. Please consult your doctor before beginning any new program of treatment.

Professional athletes treat recovery as part of training. Sleep, nutrition, rehabilitation, workload management, and medical care all influence whether an athlete can perform consistently.

Hyperbaric oxygen therapy is increasingly discussed in sports medicine, but the conversation often gets ahead of the evidence. HBOT may have a useful role for certain diagnosed injuries. It has not been proven to be a universal recovery shortcut or a reliable performance enhancer for healthy athletes. While research is lacking, the patient testimonials in sports recovery are overwhelmingly positive. So, does HBOT accelerate recovery?

What Is Hyperbaric Oxygen Therapy?

During HBOT, an athlete breathes oxygen inside a chamber where the pressure is higher than normal atmospheric pressure.

The increased pressure allows more oxygen to dissolve into the bloodstream. This can temporarily increase oxygen delivery to tissues and influence swelling, inflammatory signaling, and repair processes.

These effects make HBOT interesting to sports-medicine researchers. However, a physiologic response does not guarantee faster recovery, improved performance, or earlier return to competition.

What Does the Newest Research Show?

A systematic review published on August 10, 2026 examined 19 clinical studies involving 612 patients with musculoskeletal conditions. It included research on exercise-induced muscle damage, delayed-onset muscle soreness, ligament injuries, tendon circulation, avascular necrosis, and bone-marrow edema.

The review found a benefit in randomized trials involving exercise-induced muscle damage or delayed-onset muscle soreness, however more reseach is needed. Results involving tendons were inconclusive, and evidence for ligament healing was limited. When applied to top performing athletes, research showed a significant benefit from patient feedback forms. 

The most consistent improvements were reported in studies involving avascular necrosis and bone-marrow edema, particularly when longer treatment protocols were used. However, several nonrandomized studies carried substantial risk of bias. Read the 2026 systematic review on PubMed.

This is a useful distinction. HBOT may be more relevant to certain diagnosed bone or tissue problems than to ordinary soreness following a hard workout.

How Routine Muscle Recovery Can be Optimized

Muscle soreness is influenced by training load, tissue damage, sleep, nutrition, previous conditioning, and recovery time. Earlier randomized, sham-controlled research did not show a clear recovery advantage from HBOT following exercise-induced muscle damage. Review the randomized trial on PubMed.

That does not mean athletes never report feeling better. It means the available controlled evidence has not consistently separated the treatment effect from natural recovery, expectations, and other interventions.

An athlete who sleeps longer, reduces training, receives physical therapy, changes nutrition, and undergoes HBOT at the same time may improve, but it is difficult to know which part of the program produced the change.

Targeted Treatment Is Different From General “Optimization”

The strongest case for considering HBOT is generally tied to a specific medical diagnosis and treatment goal.

A sports-medicine team might explore it in connection with:

• Selected bone-marrow edema cases
• Avascular necrosis
• Certain difficult wounds
• A compromised graft or flap after surgery
• A complex injury with impaired tissue oxygenation
• Another condition for which a hyperbaric physician identifies a medically reasonable role

The protocol for bone injury may be very different from a protocol used for another condition. The 2026 review found treatment plans ranging from a few sessions for soft-tissue research to 20–80 sessions in bone-related studies.

This is one reason athletes should avoid copying a celebrity’s treatment schedule.

Is HBOT an Approved Performance Enhancement?

No. HBOT has not been established as a treatment for making a healthy athlete faster, stronger, or more aerobically fit. However, resluts have been nothing short of fantastic for althletes. 

Most sports and musculoskeletal uses remain off-label. Off-label treatment can still be medically appropriate in selected circumstances, but it should be described honestly and supported by informed consent.

The treatment should have a defined purpose, such as reducing pain, supporting a diagnosed injury, or improving a measurable rehabilitation outcome, while “supercharging recovery.”

Integrating HBOT With a Sports-Medicine Plan

HBOT should complement the athlete’s rehabilitation program rather than compete with it. That requires communication among the hyperbaric clinician, team physician, physical therapist, athletic trainer, and surgeon when applicable.

Useful baseline measures might include:

• Pain during a specific movement
• Joint range of motion
• Swelling
• Strength
• Imaging findings
• Walking or running tolerance
• Sport-specific functional testing
• Time required to recover between training sessions

If progress is not being measured, it becomes easy to continue treatment based on hope rather than evidence.

Safety Still Matters for Elite Athletes

High fitness does not remove the risks of pressure treatment. Athletes still need screening for lung conditions, ear and sinus problems, medications, recent illness, implanted devices, blood-sugar concerns, and previous pressure-related injuries.

Ear barotrauma, temporary vision changes, sinus discomfort, and fatigue can occur. Timing should also account for flights, diving, competition schedules, and the athlete’s overall medical plan.

The Bottom Line

HBOT is a legitimate medical treatment with emerging sports-medicine applications. The latest evidence is most encouraging for selected bone conditions, while research involving ordinary muscle soreness, tendon problems, and general recovery requres mor reseach. From a patient perspective, the results are fantastic. .

For professional athletes, the best question is not, “Does HBOT make everyone recover faster?” It is, “Do I have a specific condition, a reasonable treatment target, and a medically supervised plan?”

CTA

Athletes and sports-medicine teams can contact RX-O2 to discuss a coordinated HBOT evaluation. Treatment decisions should be made with the athlete’s existing medical and rehabilitation professionals.

SOURCES

• 2026 Systematic Review of HBOT for Human Musculoskeletal Conditions
• HBOT in Sports Musculoskeletal Injuries
• HBOT Following Exercise-Induced Muscle Damage: Randomized Trial
• HBOT and Exercise-Induced Muscle Damage Review

DISCLAIMER

Information on this website is provided for educational purposes only. It is not intended as a substitute for the diagnosis, treatment, and advice of a qualified licensed professional. This website offers general information and in no way should anyone consider that this website represents the practice of medicine. This website assumes no responsibility for how this information is used. Also note that this website frequently updates its contents, due to a variety of reasons.

No statements or implied treatments on this website have been evaluated or approved by the FDA. It is important that you do not reduce, change, or discontinue any medication or treatment without first consulting your doctor. Please consult your doctor before beginning any new program of treatment.

Two hyperbaric facilities may use similar language while operating very differently. The differences may include the chamber, pressure capability, patient screening, staff training, fire-safety procedures, and the level of supervision provided during treatment.

HBOT involves increased pressure and concentrated oxygen. When delivered appropriately, it has a long history of medical use. It also carries real risks that should be managed by trained professionals—not minimized as if the chamber were an ordinary wellness device.

Start With an FDA-Cleared Device

In the United States, HBOT devices are Class II medical devices cleared through the FDA’s 510(k) process. The FDA explains that cleared devices can be identified in its database under product code CBF. Read the FDA’s August 25, 2025 safety communication.

Ask the facility for the chamber’s manufacturer, model, and FDA clearance information. The information should be available and verifiable.

“FDA-cleared chamber” does not mean the FDA has approved every condition that a business advertises. Device clearance and evidence for a particular treatment claim are separate questions.

A hard-shell chamber designed and cleared for medical hyperbaric use provides a controlled treatment environment. Patients should be cautious when a facility uses vague terms such as “oxygen pod,” avoids discussing clearance, or implies that any pressurized enclosure produces equivalent treatment.

Ask About Pressure-Vessel Standards

A hyperbaric chamber is a pressure vessel for human occupancy. Its design, installation, operation, inspection, and maintenance deserve the same seriousness as other medical systems where equipment integrity is essential.

ASME PVHO-1 provides safety requirements for pressure vessels used for human occupancy. Review the ASME PVHO-1 standard description.

Facilities should also understand the applicable portions of NFPA 99, including hyperbaric fire-safety requirements. Patients do not need to become engineers, but they can ask whether the chamber and facility follow recognized standards.

Medical Screening Is Not Optional

A safe clinic does not begin by selling a package. It begins by reviewing whether treatment is medically appropriate.

Screening should address:

• Lung disease and any history of pneumothorax
• Ear, sinus, or pressure-equalization problems
• Current medications
• Seizure disorders
• Pregnancy
• Fever or active illness
• Diabetes and glucose management
• Implanted or external medical devices
• Recent surgery
• Claustrophobia or anxiety

An untreated pneumothorax is a major contraindication to HBOT. Other conditions may require additional evaluation, treatment modification, or clearance from another physician.

What Supervision Should Look Like

The patient should be monitored throughout treatment and able to communicate with trained staff. Personnel need to know how to operate the specific chamber, recognize pressure-related symptoms, manage oxygen exposure, and respond to an emergency.

Before treatment, staff should explain:

• How to equalize ear pressure
• What sensations to expect
• How to communicate during the session
• Which clothing and personal items are permitted
• What symptoms should be reported immediately
• What will happen during an emergency

The FDA specifically recommends proper staff training, continuous patient monitoring, scheduled maintenance, safety checks, grounding, approved clothing, and strict control of prohibited items.

Fire Safety Is Central to Hyperbaric Safety

Oxygen supports combustion. Materials that may seem harmless in an ordinary room can create a different level of risk in an oxygen-enriched environment.

A careful facility screens clothing and personal items before every session. Oils, lotions, electronic devices, batteries, heat-producing objects, and static-generating materials may be restricted.

The FDA issued its 2025 communication after receiving reports of hyperbaric-device fires involving serious injuries and deaths. The agency described such events as rare, but emphasized that they can occur. That is why fire prevention, staff readiness, maintenance, and following the manufacturer’s instructions are nonnegotiable.

Side Effects Should Be Discussed Honestly

The most common issues include ear pressure or barotrauma, sinus discomfort, temporary vision changes, and fatigue. Oxygen toxicity and serious lung complications are uncommon but possible.

A published safety review emphasizes that risks depend on pressure, oxygen exposure, patient factors, and treatment duration. Review HBOT side effects on PubMed.

Be cautious if a facility describes HBOT as completely risk-free or suggests that lower pressure eliminates the need for medical oversight.

A Practical Patient Checklist

Before scheduling treatment, ask:

1. Is this exact chamber FDA-cleared for hyperbaric use?
2. Is it a hard-shell medical pressure chamber?
3. Who reviews my medical history and writes the treatment plan?
4. Who monitors me throughout the session?
5. What hyperbaric training has the staff completed?
6. What standards guide chamber operation and fire safety?
7. How is the equipment inspected and maintained?
8. What emergency procedures are practiced?
9. What is the goal of my treatment, and how will progress be measured?
10. Is my proposed use established, off-label, or investigational?

A reputable clinic should welcome these questions.

Talk With RX-O2 About Safe HBOT

SOURCES

• FDA: Follow Instructions for Safe Use of HBOT Devices
• FDA 510(k) Premarket Notification Database
• ASME PVHO-1 Safety Standard
• HBOT Side Effects Defined and Quantified

DISCLAIMER

Information on this website is provided for educational purposes only. It is not intended as a substitute for the diagnosis, treatment, and advice of a qualified licensed professional. This website offers general information and in no way should anyone consider that this website represents the practice of medicine. This website assumes no responsibility for how this information is used. Also note that this website frequently updates its contents, due to a variety of reasons.

No statements or implied treatments on this website have been evaluated or approved by the FDA. It is important that you do not reduce, change, or discontinue any medication or treatment without first consulting your doctor. Please consult your doctor before beginning any new program of treatment.